Abstract
Background and aims: Considering the results of cost-effective analyses, the National Osteoporosis Foundation recommends osteoporosis treatment for patients with previous hip fracture. The aim of this study was to examine the application of adequate treatment for osteoporosis among patients who have had a hip fracture. We also evaluated the rate of subsequent fractures after five years. Methods: We conducted a retrospective data study, with a follow-up at five years after discharge, in a tertiary teaching hospital with orthopedic services and all medical specialities. Treatment for osteoporosis and subsequent fracture rates were evaluated in 114 patients with hip fracture. Functional status was assessed using the Barthel Index (BI). We also evaluated the rate of subsequent fractures after five years. Results: Twenty-five patients (22%) had a new fracture at some moment during the follow-up. Six percent at discharge and 12% at five years of follow-up were receiving adequate treatment for osteoporosis. After five years of follow-up, a decline in their BI persisted in 72% of the 43 surviving patients. Conclusions: Few patients were receiving adequate treatment for osteoporosis after hip fracture. Their fracture rates and functional decline were important.
Similar content being viewed by others
References
Kannus P, Niemi S, Palvanen M, Parkkari J. Fall-injuries among elderly people. Lancet 1997; 350: 1174.
Formiga F, Rivera A, Nolla JM, Pujol R. Characteristics of falls producing hip fracture in an elderly population. Gerontology 2004; 50: 118–9.
Ross PD. Osteoporosis: frequency, consequences and risk factors. Arch Intern Med 1996; 156: 1399–411.
Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization task force for osteoporosis. Osteoporos Int 1999; 10: 259–64.
Zuckerman JD. Hip fracture. N Engl J Med 1996; 334: 1519–25.
Klotzbuecher C, Ross P, Landsman P, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures. A summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721–39.
Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington DC: National Osteoporosis Foundation, 2000.
Bellantonio S, Fortinsky R, Prestwood K. How well are community-living women treated for osteoporosis after hip fracture? J Am Geriatr Soc 2001; 49: 1197–204.
Kamel HK, Hussain MS, Tariq S, Perry III HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000; 109: 326–8.
Colon-Emeric CS, Sloane R, Hawkes WG, et al. The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. Am J Med 2000; 109: 324–6.
Schroder HM. Petersen KK. Erlandsen M. Occurrence and incidence of the second hip fracture. Clin Orthop 1993; 289: 166–9.
Finsen V. Benum P. The second hip fracture. An epidemiologic study. Acta Orthop Scand 1986; 57: 431–3.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J 1965; 14: 61–5.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987: 40: 378–83.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd ed. (DSM-III-R). Washington, DC; 1987: 97–163.
Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12: 519–28.
Siris E, Miller P, Barret-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001; 286: 2815–22.
Meunier PJ. Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomised clinical trials. Int J Clin Pract 1999; 53: 122–9.
Sartori L, Adami S, Filipponi P, Crepaldi G. Injectable bisphosphonates in the treatment of postmenopausal osteoporosis. Aging Clin Exp Res 2003; 15: 271–83.
Masud T, Giannini S. Preventing osteoporotic fractures with bisphosphonates: a review of the efficacy and tolerability. Aging Clin Esp Res 2003; 15: 89–98.
Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23: 570–8.
Bauer DC. Osteoporotic fractures: ignorance is bliss. Am J Med 2000; 109: 338–9.
Doherty DA, Sanders KM, Kotowicz MA, Prince RL. Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos Int 2001; 12: 16–23.
Dirschl DR, Henderson RC, Oakley WC. Accelerated bone mineral loss following a hip fracture: a prospective longitudinal study. Bone 1997; 20: 79–82.
Dretakis KE, Dretakis EK, Papakitsou EF, Psarakis S, Steriopoulos K. Possible predisposing factors for the second hip fracture. Calcif Tissue Int 1998; 62: 366–9.
Werner P, Vered I. The diagnosis of osteoporosis: attitudes and knowledge of Israeli physicians. Aging Clin Esp Res 2002; 14: 52–9.
De Laet CE, Van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross-sectional analysis. BMJ 1997; 315: 221–5.
Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309: 691–5.
Pal B. Questionnaire survey of advice given to patients with fractures. BMJ 1999; 418: 500–1.
Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998; 57: 378–9.
Torgerson DJ. Dolan P. Drug treatments that reduce fracture rate are underused after vertebral fractures. BMJ 1999; 318: 1698.
Khan S, de Geus C, Holroyd B, Russel A. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med 2001; 161: 1309–12.
Francis RM, Baillie SP, Chuck AJ, et al. Management of osteoporosis in patients with hip fractures. QJM 2000; 93: 501–6.
Rubenstein L. Hip protectors: a breakthrough in fracture prevention. N Engl J Med 2000; 343: 1562–3.
Kannus P, Parkkari J, Niemi S, et al. Prevention of hip fracture in elderly people with use of hip protector. N Engl J Med 2000; 343: 1506–13.
Salkeld G, Cameron ID, dimming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BJM 2000; 320: 341–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Formiga, F., Rivera, A., Nolla, J.M. et al. Failure to treat osteoporosis and the risk of subsequent fractures in elderly patients with previous hip fracture: a five-year retrospective study. Aging Clin Exp Res 17, 96–99 (2005). https://doi.org/10.1007/BF03324580
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324580